ArticleFrontiers in oncology2018

Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer.

Jingquan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.